Alpha-1-antitrypsin (CSL Behring)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlpha-1-antitrypsin (CSL Behring)
Drug Alias NameAPIAPI InhaleAAT - CSL BehringAlpha-1 proteinase inhibitor-CSL BehringAlpha-antitrypsin-CSL Behring +[9] 
ClassificationBiologics > Blood components
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsGraft vs Host DiseaseGenetic Diseases, InbornLung Diseases +[5] 
Global Approved IndicationsGenetic Diseases, InbornLung Diseasesalpha 1-Antitrypsin Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/07/08
Country/TerritoryUnited StatesEUJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl BehringCsl Behring GmbhGrifols Therapeutics Llc
Inactive CompaniesUniversity Of Michigan Rogel Cancer Center
Active IndicationsGraft vs Host DiseaseGenetic Diseases, InbornLung Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeB02AB02
Related LinksWikipedia